PITTSBURGH — Bayer on Tuesday announced that on July 1, Philip Blake will become senior Bayer representative USA, following a common company practice of assigning this oversight role to a senior executive already holding a significant business role or roles within the region.
“Phil Blake is a highly valued and respected leader at Bayer,” stated Richard Pott, member of the management board of Bayer. “Having been with Bayer for more than 30 years, he brings a wealth of experience to this new role.”
In this new role, Blake assumes leadership of Bayer corporate operations in the U.S. from Greg Babe, who recently announced his planned retirement from Bayer. In 2011, Bayer’s U.S. operations recorded annual sales of $9.8 billion.
Blake has also been named Bayer healthCare representative USA and will maintain his position as U.S. region head of Bayer HealthCare Pharmaceuticals, the U.S.-based specialty pharmaceuticals division of Bayer HealthCare.
With construction underway for a new consolidated U.S. Bayer HealthCare site in Whippany, N.J., Blake will maintain his primary office in that location.
Blake was previously head of Bayer Inc., a Canadian subsidiary of Bayer AG, and head of Bayer HealthCare in Canada. In his 30-year career with Bayer, Blake has held leadership positions around the world focusing on global strategic product marketing, business development, clinical planning, product development and sales management.
Blake attended Bristol University and Oxford University Business School in the United Kingdom, with extended business training at INSEAD Fontainbleu in Paris, France, and the Wharton Business School in Philadelphia. He is also a Chartered Corporate Director – earning this designation in 2006 from the Directors College at the DeGroote School of Business, McMaster University.
He is married and has two children.